A Richter transformation PD-1 block party
- PMID: 28663221
- DOI: 10.1182/blood-2017-05-781229
A Richter transformation PD-1 block party
Conflict of interest statement
Conflict-of-interest disclosure: J.M.P. is a consultant for Pharmacyclics and Gilead Pharmaceuticals.
Comment on
-
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.Blood. 2017 Jun 29;129(26):3419-3427. doi: 10.1182/blood-2017-02-765685. Epub 2017 Apr 19. Blood. 2017. PMID: 28424162 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources

